Antibiotic prophylaxis in the era of multidrug-resistant bacteria

Author： Wittekamp Bastiaan HJ   Bonten Marc. JM  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.6, 2012-06, pp. : 767-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Nanoparticles in the Inhibition of Multidrug-Resistant Bacteria and Biofilms

By  

Current Drug Delivery, Vol. 15, Iss. 4, 2018-04 ,pp. : 470-484

Bentham Science Publishers

Access to resources Recommend Favorite

Microbial Biofilm and Quorum Sensing Inhibition: Endowment of Medicinal Plants to Combat Multidrug-Resistant Bacteria

By  

Current Drug Targets, Vol. 19, Iss. 16, 2018-12 ,pp. : 1916-1932

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoroquinolones, surgery in multidrug-resistant TB

By  

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Multidrug-resistant TB `a curable disease'

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I.   Colebunders R.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite